AEON Biopharma Competitors and Similar CompaniesClear all

AEON Biopharma's competitors and similar companies include Vigil Neuroscience, e-therapeutics and Domain Therapeutics.

	AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.	Vigil Neuroscience Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases.	e-therapeutics e-therapeutics is a computational drug discovery company.	Domain Therapeutics Domain Therapeutics is a biopharmaceutical company.
Founding Date	Founding Date 2012	Founding Date 2020	Founding Date 2003	Founding Date 2001
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma
Locations	Locations Irvine, US HQ Newport Beach, US	Locations Cambridge, US HQ	Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB	Locations Illkirch-Graffenstaden, FR HQ Montréal, CA
Employees	Employees 6	Employees 34	Employees 58	Employees 811% decrease
Valuation ($)	Valuation ($) 39.5 m	Valuation ($) 151.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($39.2m) (FY, 2025)	Net income ($84.3m) (FY, 2024)	Net income (£14.9m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 112.6m	Total funding raised $ 140m	Total funding raised $ 66.8m	Total funding raised $ 41.5m